Ferrochelatase is a therapeutic target for ocular neovascularization

Ocular neovascularization underlies major blinding eye diseases such as “wet” age‐related macular degeneration (AMD). Despite the successes of treatments targeting the vascular endothelial growth factor (VEGF) pathway, resistant and refractory patient populations necessitate discovery of new therape...

Descripción completa

Detalles Bibliográficos
Autores principales: Basavarajappa, Halesha D, Sulaiman, Rania S, Qi, Xiaoping, Shetty, Trupti, Sheik Pran Babu, Sardar, Sishtla, Kamakshi L, Lee, Bit, Quigley, Judith, Alkhairy, Sameerah, Briggs, Christian M, Gupta, Kamna, Tang, Buyun, Shadmand, Mehdi, Grant, Maria B, Boulton, Michael E, Seo, Seung‐Yong, Corson, Timothy W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452042/
https://www.ncbi.nlm.nih.gov/pubmed/28377496
http://dx.doi.org/10.15252/emmm.201606561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452042/
https://www.ncbi.nlm.nih.gov/pubmed/28377496
http://dx.doi.org/10.15252/emmm.201606561

Ejemplares similares